The global dental services market was valued at USD 432.1 billion in 2022 and is projected to reach USD 699.7 billion by 2032, growing at a steady annual rate of 4.93% between 2023 and 2032. This growth is largely driven by rising awareness and demand for cosmetic dentistry, along with an increasing focus on oral health worldwide.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5022
The COVID-19 pandemic significantly disrupted dental care. In the early months of the outbreak, many dental offices closed except for emergencies. Even after reopening, patient volume remained low. A survey by the American Dental Association in August 2020 found that while nearly all dentists had reopened, over half reported fewer patients than usual. Initially, the ADA advised postponing non-urgent procedures, including routine checkups, cleanings, and cosmetic surgeries, while emergency services continued for issues like painful cavities and facial injuries.
The COVID-19 epidemic has had a tremendous impact on the healthcare system, particularly the dental industry. When the virus first expanded across the United States in March and April, many dentist offices closed save for emergencies. Even after they reopened, changes were still evident. A study of dentists by the American Dental Association during the week of August 10 found that 98.9% of them were open, but that only 47.6% reported “business as usual” and 51.3% reported “lower patient volume than usual.”
According to data from the American Dental Association’s Health Policy Institute (HPI), the dental industry was at a standstill as a result of COVID-19 since dental clinics were only allowed for emergency cases in the early phases of the pandemic. In March 2020, the American Dental Association (ADA) issued a public advisory urging people to postpone elective dental procedures. The ADA lists the procedures that are required to be postponed as oral exams, radiography, routine cleanings, cosmetic surgeries, and orthodontic procedures without pain medication. Dental or facial traumas, painful caries, oral bleeding, and abnormal tissue biopsies, emergency dental services were offered.
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More